Immunocore

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunocore and other ETFs, options, and stocks.

About IMCR

Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. 

CEO
Bahija Jallal
CEOBahija Jallal
Employees
497
Employees497
Headquarters
Abingdon, Oxfordshire
HeadquartersAbingdon, Oxfordshire
Founded
2021
Founded2021
Employees
497
Employees497

IMCR Key Statistics

Market cap
3.32B
Market cap3.32B
Price-Earnings ratio
-22.32
Price-Earnings ratio-22.32
Dividend yield
Dividend yield
Average volume
336.75K
Average volume336.75K
High today
$65.43
High today$65.43
Low today
$63.13
Low today$63.13
Open price
$63.50
Open price$63.50
Volume
103.32K
Volume103.32K
52 Week high
$76.98
52 Week high$76.98
52 Week low
$42.21
52 Week low$42.21

Analyst ratings

94%

of 17 ratings
Buy
94.1%
Hold
5.9%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.